Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Trial details
- Registry ID
- NCT03687242
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal HyperplasiaNCT03687242 | Spruce Biosciences | Phase 2 | Completed | 2019-07-08Actual |
| Study of SPR001 in Adults With Classic Congenital Adrenal HyperplasiaNCT03257462 | Spruce Biosciences | Phase 2 | Completed | 2019-03-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |